Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by alnovaon Mar 25, 2019 12:16pm

70 Views

Post# 29531966

Red

The mere mention of a 10:1 makes me shudder. I've yet to see one that works out for the investor. Not to mention that this would still not get SVA trading at a qualifying level for a Nasdaq listing. You would NOT see a share price of $1.60 from .16 regardless. More likely something like .90!!! With insiders like Dr.T. holding a large position themselves, I would like to think this is not a thought they are pursuing. I don't know what it will take, but we need to trade at a higher level on the market we are on for now, and then maybe dream big about a US listing. Talk of a Nasdaq listing at this point is very premature. These are only my thoughts, so please feel free to share yours as well.

Bullboard Posts

Debt-free cannabis company set for next stage of growth